Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02736786 · ClinicalTrials.gov registry record
A Study of Mucosal Sparing Proton Beam Therapy (PBT) in Resected Oropharyngeal Tumors
A clinical trial of Oropharyngeal Tumor, sponsored by Mayo Clinic.
- Completed
- Registry status
- 64
- Enrollment target
- 2
- Study locations
NCT02736786: Completed study of Oropharyngeal Tumor, sponsored by Mayo Clinic.
NCT02736786 is a study of Oropharyngeal Tumor that has completed, run by Mayo Clinic. The registered enrollment target is 64 participants. The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02736786, a study of Oropharyngeal Tumor, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 64 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study is an observational study evaluating the clinical outcomes of mucosal sparing proton beam therapy (PBT) after resection of favorable risk oropharyngeal cancer patients. Subjects will be screened at outpatient clinic visit appointments and interested qualified subjects will be consented and offered participation in this study. Once consent has been obtained baseline adverse event and Quality of Life (QOL) data will be collected and subjects will undergo adjuvant PBT and follow-up at 3 months, 12 months, and 24 months. No study-specific visits or evaluations will be required. Patients will be evaluated according to the physician's standard practice and discretion. Patient data will be drawn from the patients' medical records and reported by means of a web-based electronic data collection (EDC) system. Patients will be considered "on study" until 24 months of observation has occurred, withdrawal of consent, lost to follow-up, or study closure.
Primary Outcome
Local control rate will be assessed by standard of care head and neck clinical examination during routine followup visits
Conditions Studied
Study Locations (2)
Arizona
- Mayo Clinic - Phoenix
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2016-03 |
| Est. Completion | 2021-08-23 |
What the finished NCT02736786 record still lists
NCT02736786 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 64 participants, a relatively small participant target.
The record links to 1 condition, with Oropharyngeal Tumor appearing as the primary indexed condition, and to 0 interventions.
NCT02736786 reports a single indexed study location in Arizona, Minnesota.
Frequently Asked Questions
What is clinical trial NCT02736786 about?
NCT02736786 is a clinical study titled "A Study of Mucosal Sparing Proton Beam Therapy (PBT) in Resected Oropharyngeal Tumors". This study is an observational study evaluating the clinical outcomes of mucosal sparing proton beam therapy (PBT) after resection of favorable risk oropharyngeal cancer patients. Subjects will be screened at outpatient clinic visit appointments and interested qualified subjects will be consented an...
What is the current status of trial NCT02736786?
This trial is currently completed. The enrollment target is 64 participants. The study started on 2016-03. Estimated completion is 2021-08-23.
What conditions does trial NCT02736786 study?
This clinical trial studies the following conditions: Oropharyngeal Tumor.
Who is sponsoring clinical trial NCT02736786?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02736786 being conducted?
This trial has 2 study locations across Arizona, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01853631 · 64 participants · Phase 1
Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)
- NCT03739502 · 64 participants · Phase 2
A Randomized Phase II Study of Hyperbaric Oxygen in Improving Engraftment in Umbilical Cord Blood Stem Cell Transplant
- NCT03739814 · 64 participants · Phase 2
Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
- NCT03866408 · 64 participants · Early Phase 1
Insulin Regulation of Lipolysis and Lipolysis Proteins
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia